Is HUM undervalued? Intrinsic value estimate stands at $520.
Get informed when a big investor buys or sells
+ Follow$517.35
Undervalued by 34.4% based on the discounted cash flow analysis.
Humana (HUM) currently reports a DCF fair value of $520. Use the charts on this page to explore Humana's DCF fair value history and peer comparisons.
Humana's discounted cash flow (DCF) fair value estimate is $520, about 34.4% undervalued versus the current market price. DCF models project future free cash flows and discount them back to today — so the result depends on growth, margin, and discount-rate assumptions. Use it as one valuation lens alongside multiples and peer checks on Stockcircle.
Start with the current DCF fair value of $520, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Humana, and consider following HUM for alerts when major investors trade the stock.
Humana is classified in the Healthcare sector. On DCF fair value, it currently shows $520. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HUM with unrelated industries.